|
Volumn 339, Issue 21, 1998, Pages 1549-1550
|
Combination therapy for hepatitis C infection
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA INTERFERON;
AMINOTRANSFERASE;
RIBAVIRIN;
VIRUS DNA;
VIRUS RNA;
ANTIVIRAL ACTIVITY;
BONE MARROW SUPPRESSION;
DRUG EFFICACY;
DRUG SAFETY;
EDITORIAL;
HEMOLYTIC ANEMIA;
HEPATITIS C;
HEPATITIS C VIRUS;
HUMAN;
PRIORITY JOURNAL;
TREATMENT OUTCOME;
ANTIVIRAL AGENTS;
DRUG THERAPY, COMBINATION;
HEPATITIS C, CHRONIC;
HUMANS;
INTERFERON ALFA-2B;
RIBAVIRIN;
VIRAL LOAD;
|
EID: 0032548032
PISSN: 00284793
EISSN: None
Source Type: Journal
DOI: 10.1056/NEJM199811193392112 Document Type: Editorial |
Times cited : (43)
|
References (18)
|